Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00293540
What this trial is testing

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 249
Not applicableStudy completedNCT06016725
What this trial is testing

Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 75
Early research (Phase 1)Study completedNCT02219789
What this trial is testing

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+3 more
Mayo Clinic 10
Not applicableUnknownNCT00898690
What this trial is testing

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 120
Large-scale testing (Phase 3)Looking for participantsNCT04852887
What this trial is testing

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Who this might be right for
Stage I Breast Cancer
NRG Oncology 1,670
Large-scale testing (Phase 3)Study completedNCT01810393
What this trial is testing

Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years

Who this might be right for
Breast Cancer
Hoffmann-La Roche 114
Large-scale testing (Phase 3)UnknownNCT00430001
What this trial is testing

Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Danish Breast Cancer Cooperative Group 300
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT00467844
What this trial is testing

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Who this might be right for
Cachexia
GTx 159
Large-scale testing (Phase 3)Ended earlyNCT05207709
What this trial is testing

Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 61
Not applicableActive Not RecruitingNCT03766009
What this trial is testing

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

Who this might be right for
Breast Cancer Stage 0Breast Cancer Stage IBreast Cancer Stage II+1 more
Alliance for Clinical Trials in Oncology 627
Testing effectiveness (Phase 2)Study completedNCT00654836
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Loyola University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04862663
What this trial is testing

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 893
Testing effectiveness (Phase 2)Looking for participantsNCT07327021
What this trial is testing

MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC

Who this might be right for
TNBC, Triple Negative Breast CancerEarly Breast Cancer
Tel-Aviv Sourasky Medical Center 54
Large-scale testing (Phase 3)Study completedNCT00381901
What this trial is testing

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
National Cancer Institute, France 3,400
Not applicableStudy completedNCT05086731
What this trial is testing

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Emory University 33
Testing effectiveness (Phase 2)Study completedNCT00090857
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 49
Large-scale testing (Phase 3)Ended earlyNCT00543127
What this trial is testing

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 870
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Large-scale testing (Phase 3)Study completedNCT00201851
What this trial is testing

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 740
Next Page